Abecma Approved for Earlier Lines in R/R Multiple Myeloma
The US Food and Drug Administration (FDA) has approved idecabtagene vicleucel (ide-cel) (Abecma, Bristol-Myers Squibb/2seventy bio) for adults with relapsed ...
Read moreThe US Food and Drug Administration (FDA) has approved idecabtagene vicleucel (ide-cel) (Abecma, Bristol-Myers Squibb/2seventy bio) for adults with relapsed ...
Read more© 2023 earth-news.info
..................................%%%...*...........................................$$$$$$$$$$$$$$$$$$$$--------------------.....